Thyrotropin dependent Well-Differentiated Thyroid Cancer

Drug	Drug Name	Drug Description
DB00451	Levothyroxine	A synthetic T4 hormone used to treat hypothyroidism that can be used along with surgery and radioiodine therapy to manage thyrotropin-dependent well-differentiated thyroid cancer.

Drug	Drug Name	Target	Type
DB00451	Levothyroxine	Thyroid hormone receptor alpha	target
DB00451	Levothyroxine	Thyroid hormone receptor beta	target
DB00451	Levothyroxine	Cytochrome P450 2C8	enzyme
DB00451	Levothyroxine	Transthyretin	carrier
DB00451	Levothyroxine	Serum albumin	carrier
DB00451	Levothyroxine	Thyroxine-binding globulin	carrier
DB00451	Levothyroxine	P-glycoprotein 1	transporter
DB00451	Levothyroxine	Monocarboxylate transporter 8	transporter
DB00451	Levothyroxine	Solute carrier organic anion transporter family member 1C1	transporter
DB00451	Levothyroxine	Solute carrier organic anion transporter family member 1A2	transporter
DB00451	Levothyroxine	Solute carrier organic anion transporter family member 1B1	transporter
DB00451	Levothyroxine	Solute carrier organic anion transporter family member 4A1	transporter
DB00451	Levothyroxine	Large neutral amino acids transporter small subunit 1	transporter
DB00451	Levothyroxine	UDP-glucuronosyltransferase 1-1	enzyme
DB00451	Levothyroxine	Solute carrier organic anion transporter family member 2B1	transporter
DB00451	Levothyroxine	Integrin alpha-V	target
DB00451	Levothyroxine	Integrin beta-3	target
DB00451	Levothyroxine	P-glycoprotein 1	enzyme

Drug	Drug Name	Phase	Status	Count